Vnitr Lek 2014, 60(5-6):535-538

Význam stanovení natriuretických peptidů a prokalcitoninu u akutního srdečního selhání

Antonín Jabor*, Janka Franeková
Pracoviště laboratorních metod IKEM a 3. LF UK, Praha, přednosta prof. MUDr. Antonín Jabor, CSc.

Received: May 29, 2014; Published: May 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jabor A, Franeková J. Význam stanovení natriuretických peptidů a prokalcitoninu u akutního srdečního selhání. Vnitr Lek. 2014;60(5-6):535-538.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. McMurray JJV et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur J Heart Fail 2012; 14(8): 803-869. Go to original source... Go to PubMed...
    2. Yancy CW et al. 2013 ACCF/AHA Guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. Published on line June 5, 2013.
    3. Wacker C, Prkno A, Brunkhorst FM et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013; 13: 426-435. Go to original source... Go to PubMed...
    4. Cohn B Con procalcitonin differentiate sepsis from systemic inflammatory response syndrome without infection? Ann Emerg Med 2014; 63: 631-632.
    5. Dellinger RP, Levy MM, Rhodes A et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637. Go to original source... Go to PubMed...
    6. Reinhart K, Bauer M, Riedemann NC et al. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rews 2012; 25: 609-634. Go to original source... Go to PubMed...
    7. Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 2010; 14: R15. Go to original source... Go to PubMed...
    8. Giamarellos-Bourboulis EJ, Tsangaris I, Kanni T et al. Procalcitonin as an early indicator of outcome in sepsis: a prospective observational study. J Hosp Infection 2011; 77: 58-63. Go to original source... Go to PubMed...
    9. Schuetz P, Chiappa V, Briel M et al. Procalcitonin algorithms for antibiotic therapy decisions. Arch Intern Med 2011; 171: 1322-1331. Go to original source... Go to PubMed...
    10. Sandifer JP, Jones AE Can procalcitonin levels guide antibiotic therapy in bacterial infections and reduce antibiotic overconsumption without having a negative effect on clinical outcome? Ann Emerg Med 2012; 60: 370-371. Go to original source... Go to PubMed...
    11. Maisel A, Neath SX, Landsberg J et al. Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. Eur J Hert Failure 2012; 14: 278-286. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.